Showing 101-120 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Coenzyme Q10 for Parkinson's disease
Cochrane Systematic Reviews, 16-Apr-2012
A number of preclinical studies in both in vitro and in vivo models of Parkinson's disease have demonstrated that coenzyme Q10 can protect the nigrostriatal dopaminergic system. Some clinical trials have looked at the neuroprotective effects of coenzyme Q
- Cognitive behaviour therapy for chronic fatigue syndrome in adults
Cochrane Systematic Reviews, 16-Jul-2008
Chronic fatigue syndrome (CFS) is a common, debilitating and serious health problem. Cognitive behaviour therapy (CBT) may help to alleviate the symptoms of CFS.
- Cognitive behavioural interventions for sleep problems in adults aged 60+
Cochrane Systematic Reviews, 20-Jan-2003
The prevalence of sleep problems in adulthood increases with age. While not all sleep changes are pathological in later life, severe disturbances may lead to depression, cognitive impairments, deterioration of quality of life, significant stresses for car
- Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
Cochrane Systematic Reviews, 5-Jun-2013
Cognitive impairments, particularly memory problems, are a defining feature of the early stages of Alzheimer's disease (AD) and vascular dementia. Cognitive training and cognitive rehabilitation are specific interventional approaches designed to address d
- Combined vitamin B6‐magnesium treatment in autism spectrum disorder
Cochrane Systematic Reviews, 19-Oct-2005
The use of mega-vitamin intervention began in the 1950s with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with "autism syndrome" when speech and language improvement was observed in some children
- Common antiepileptic drugs in pregnancy in women with epilepsy
Cochrane Systematic Reviews, 17-Dec-2015
The potential adverse effects of antiepileptic drug (AED) exposure in pregnancy have been well recognised but the relative risks of specific antiepileptic drug exposures remain poorly understood.
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
Cochrane Systematic Reviews, 15-Aug-2012
Patients with Parkinson's disease commonly suffer from speech and voice difficulties such as impaired articulation and reduced loudness. Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques
- Constraint‐induced movement therapy for upper extremities in people with stroke
Cochrane Systematic Reviews, 8-Oct-2015
In people who have had a stroke, upper limb paresis affects many activities of daily life. Reducing disability is therefore a major aim of rehabilitative interventions. Despite preserving or recovering movement ability after stroke, sometimes people do no
- Constraint‐induced movement therapy in children with unilateral cerebral palsy
Cochrane Systematic Reviews, 1-Apr-2019
Unilateral cerebral palsy (CP) is a condition that affects muscle control and function on one side of the body. Children with unilateral CP experience difficulties using their hands together secondary to disturbances that occur in the developing fetal or
- Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea
Cochrane Systematic Reviews, 26-Jun-2014
Continuous positive airway pressure (CPAP) is the mainstay of therapy for moderate to severe obstructive sleep apnoea (OSA). However, compliance with CPAP has been less than ideal. There are many different CPAP interfaces now available for the treatment o
- Continuous positive airways pressure for obstructive sleep apnoea in adults
Cochrane Systematic Reviews, 19-Jul-2006
Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature de
- Cooling for newborns with hypoxic ischaemic encephalopathy
Cochrane Systematic Reviews, 31-Jan-2013
Newborn animal studies and pilot studies in humans suggest that mild hypothermia following peripartum hypoxia-ischaemia in newborn infants may reduce neurological sequelae without adverse effects.
- Corticosteroids for acute bacterial meningitis
Cochrane Systematic Reviews, 12-Sep-2015
In experimental studies, the outcome of bacterial meningitis has been related to the severity of inflammation in the subarachnoid space. Corticosteroids reduce this inflammatory response.
- Corticosteroids for acute traumatic brain injury
Cochrane Systematic Reviews, 24-Jan-2005
Traumatic brain injury is a leading cause of death and disability. Corticosteroids have been widely used in treating people with traumatic brain injury.
- Corticosteroids for Bell's palsy (idiopathic facial paralysis)
Cochrane Systematic Reviews, 18-Jul-2016
Inflammation and oedema of the facial nerve are implicated in causing Bell's palsy. Corticosteroids have a potent anti-inflammatory action that should minimise nerve damage. This is an update of a review first published in 2002 and last updated in 2010.
- Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 29-Nov-2017
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing and remitting paralysing illness, probably due to an autoimmune response, which should benefit from corticosteroid treatment. Non-randomised studies suggest tha
- Corticosteroids for Guillain‐Barré syndrome
Cochrane Systematic Reviews, 24-Oct-2016
Guillain-Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be expected to benefit.
- Corticosteroids for managing tuberculous meningitis
Cochrane Systematic Reviews, 28-Apr-2016
Tuberculous meningitis is a serious form of tuberculosis (TB) that affects the meninges that cover a person's brain and spinal cord. It is associated with high death rates and with disability in people who survive. Corticosteroids have been used as an adj
- Corticosteroids for myasthenia gravis
Cochrane Systematic Reviews, 20-Apr-2005
Although widely accepted as an appropriate immunosuppressive therapy, the efficacy of glucocorticosteroid treatment has only rarely been tested in controlled studies. This is an update of a Cochrane review first published in 2005 and previously updated in
- Corticosteroids for preventing postherpetic neuralgia
Cochrane Systematic Reviews, 28-Mar-2013
Postherpetic neuralgia is a common, serious painful complication of herpes zoster. Corticosteroids are anti-inflammatory and might be beneficial. This is an update of a review first published in 2008 and previously updated in 2010.
